MPN Care: How Can Molecular Testing Help?

Published on

Topics include: What Are Myeloproliferative Neoplasms?

What can doctors anticipate from a person’s myeloproliferative neoplasm (MPN) by understanding their genetic subtype? How does mutational status impact treatment decisions? MPN expert Dr. Eytan Stein, from Memorial Sloan Kettering Cancer Center, joined Patient Power to discuss the value of genetic testing, common mutations seen in MPNs and how the results can influence care. Dr. Stein also gives updates on targeted therapies in development for MPNs. Watch now to find out more.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View more programs featuring and

Related Programs

Can Hypomethylating Agents Be Used for MPNs?

What are hypomethylating agents, and can MPN patients benefit from them? Watch as Dr. Guillermo Garcia-Manero discusses studies on them for MPN treatment.


ASH 2018 Daily Wrap: MPN News

On location in San Diego, Patient Power founders Andrew and Esther Schorr are joined by a panel of experts to discuss research developments announced at ASH 2018. Watch day one of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.


Everyone’s MPN Is Different: What You Should Know About Genetic Mutations

Should you get a genetic test? Watch as MPN experts Dr. Alison Moliterno and Dr. Stephen Oh explain the driver mutations associated with MPNs and why they are important in MPN treatment.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on July 25, 2019